Reference number : 236-2012-2013-Q4-00572, amendment number : , agreement type : G, recipient legal name : MIN, Wei-Ping, recipient country : CA, recipient province : ON, recipient city : London, recipient postal code : N6A 3K7, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 313349.0, agreement start date : 2013-04-01, agreement end date : 2016-03-31, description english : The role of IDO1 vs IDO2 on tumour immune evasion  and immune therapy, description french : The role of IDO1 vs IDO2 on tumour immune evasion  and immune therapy, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2013-14 to 2015-16), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2013-14 à 2015-16), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada